It suggested that the presence of HLA-DQ2 in 90% of CD subjects reduced T-helper interactions, down-regulated cytokine production such as IL-4 and IFN γ, and may alleviate COVID-19 symptoms among CD or RCD cases (54). Here, IL4 is linked to COVID-19.